Cell growth is the orderly synthesis of protoplasm, and involves the highly coordinated formation of a great number of macromolecules. It is the task of cell physiology to account for this orderliness by discovering the special mechanisms that integrate hundreds of potentially independent biochemical reactions so effectively that a single functional unit is generated.
One simple but effective way to illustrate the operation of control devices in bacterial cells is to examine the network of controls that radiates out from individual amino acids, linking them to most of the cell's biosynthetic processes. This network can be revealed by the following simple experiment. Establish a culture in balanced growth in a chemostat with some amino acid as the restricting nutrilite and then, while carefully monitoring several major cell processes, suddenly reduce the rate of supply of the amino acid by a factor of two. Within 1 to 10 min, the cells of such a culture exhibit at least six major responses (Table 1) . The rapidity of these responses in cells with perhaps a 60-to 100-min generation time indicates that they occur independently of any long-term effect of amino acid restriction, such as reduced enzyme levels.
(i) The first effect noted in Table 1 is really a metabolic consequence of amino acid restriction rather than a regulatory response: protein synthesis, within 1 min, is diminished by a factor of two. The postulated cause, a reduced level of aminoacyl soluble ribonucleic acid (sRNA), appears at first glance to be obvious and undeserving of further comment. Nevertheless, the molecular details of the consequence of an amino acid restriction are far from clear. Direct measurements of the in vivo state of charging of sRNA molecules in some instances show only a slight reduction in charging level upon complete amino 1 (43) have presented evidence that a portion of sRNA is acylated with compounds other than single amino acids. An alternative possibility is that the complete discharge of one species of sRNA blocks protein synthesis and thereby prevents the discharge of any other species of sRNA bearing the same amino acid. Another interesting facet of amino acid deprivation is that it causes a rapid disappearance of polysomes (24) . It is possible, therefore, that partial restriction of the supply of an amino acid (or its sRNA derivative) causes a proportional reduction in polysome content. If this were the case, then reducing the supply of an amino acid by a factor of two would halve the overall rate of protein synthesis by halving the number of growing polypeptide chains rather than by reducing the rate of growth of individual chains.
(ii) Within 1 min of imposing an amino acid restriction, the accumulation of RNA virtually ceases. Some synthesis of messenger RNA (mRNA) continues, perhaps at a reduced rate, but there is no accumulation of ribosomal or soluble RNA for almost a generation time. Such a marked though transient decrease in total RNA synthesis as a result of a moderate reduction in amino acid supply is actually typical of many conditions that restrict protein synthesis in bacteria (27) . The mechanism of this response is not known; contemporary theories postulate, alternatively, (i) that uncharged sRNA inhibits RNA polymerase (18, 37, 38) , (ii) that a special protein must be made to permit RNA accumulation (1, 2) , (iii) that reduced protein synthesis disaggregates polysomes and releases an inhibitor of RNA synthesis (23, 24) , and (iv) that such polysome disaggregation disrupts the stripping off of ribosomal RNA from its deoxyribonucleic acid (DNA) template (36) .
(iii) DNA synthesis continues at a gradually diminishing rate for perhaps 30 min, permitting a 40 to 50ec increase, after which its velocity becomes adjusted to the new lower rate of growth. This behavior has been ascribed to a requirement for the synthesis of a specific protein to permit the initiation of new rounds of DNA replication. The experimental evidence for this picture and a specific model for the regulation of DNA replication have been presented by Lark (19) .
(iv) Beginning 5 to 10 min after the shift down in amino acid supply, a marked derepression of the enzymes concerned with the biosynthesis of the restricted amino acid occurs, presumably as a result of a reduced intracellular concentration of a repressing derivative of the amino acid (39) .
(v) Most amino acids have the ability to inhibit the activity of one of the early enzymes in its biosynthetic pathway. Amino acid restriction quickly releases this inhibition and permits a flow of carbon skeletons along the particular pathway (39) .
(vi) A near-total repression of many catabolic enzymes begins within a few minutes of the amino acid shift down. The current view of this phenomenon postulates the following chain of events. Restriction of any amino acid slows down protein synthesis, causing a surplus of the 19 other amino acids [and adenosine triphosphate (ATP)], each of which shuts off its own biosynthetic pathway and thus contributes to a build-up of intermediary catabolites which are corepressors of catabolic enzymes (see 20) .
There may be responses in addition to these six. Possibly, for example, protein degradation might be initiated. During unrestricted batch culture, the turnover of bacterial proteins is almost immeasurably slow. Upon total starvation for NH4+ and an amino acid, a great increase in the rate of protein turnover ensues, Of the six known responses to amino acid restriction, only the first is a straightforward metabolic consequence of the imposed stress; the remaining five appear to be homeostatic responses, each of which reflects the operation of a separate device for physiological integration. The multiple regulatory involvements of each amino acid make all the more intriguing the question of their biochemical mechanism.
Key Position of Aminoacyl sRNA Synthetases
One of the first questions one might ask is whether it is the amino acid itself or a derivative of it that plays each of these several physiological roles. For end-product inhibition it seems fairly certain that the amino acid itself is involved, whereas for regulation of DNA synthesis it appears that the amino acid requirement is a secondary consequence of the fact that a regulatory protein must be made. For the other regulatory devices the matter is less certain, and is a subject of much current interest. Figure 1 briefly shows the major features of the metabolism of an (for simplicity's sake, nondegradable) amino acid: (i) a series of linked, enzymatic reactions (four are shown) converting a precursor catabolite into the amino acid; (ii) an alternative source of the amino acid, preformed, from the medium; (iii) activation of the amino acid and its attachment to one or more specific sRNA molecules by an appropriate aminoacyl sRNA synthetase; (iv) incorporation of the aminoacyl group into growing polypeptide chains via the polysome system.
The aminoacyl sRNA synthetase, or activating enzyme, is a particularly crucial element in the route leading from amino acid to protein. Because of the adaptor function of sRNA, the successful assembly of proteins depends on the fidelity with which each aminoacyl sRNA synthetase distinguishes one particular amino acid from 19 others and one particular sRNA from perhaps 40 others.
The reaction catalyzed by an aminoacyl sRNA synthetase is shown in Fig. 2 . It is generally pictured as proceeding in two biochemically distinct steps. In the first step, the enzyme binds its cognate amino acid and ATP and, in the presence of Mg+2, catalyzes the activation of the aminoacyl group by a pyrophosphorolytic split of ATP to form the aminoacyl adenylate and inorganic pyrophosphate. This reaction is reversible, and is the basis of the pyrophosphate (P3-labeled)-ATP exchange assay for these enzymes. The hydroxamate assay also measures this first step, but by the formation, in the presence of hydroxylamine, of the aminoacyl hydroxamate derivative. Under physiological conditions, the aminoacyl adenylate formed in the first step does not dissociate from the enzyme; instead, a second reaction occurs in which the aminoacyl group is transferred to a specific sRNA molecule, releasing adenylic acid. The overall reaction is customarily studied by measuring the attachment of C14-amino acid to sRNA. This assay technique certainly comes closest to measuring the physiological reaction, yet even it departs in one significant respect from biological reality. In the cell, the sRNA molecules do not vastly outnumber the synthetase molecules, whereas in the in vitro assay system the sRNA must of course be added in substrate-like rather than cofactor-like concentrations.
Until recently it has been assumed that there is but one aminoacyl sRNA synthetase for each amino acid, despite the knowledge that more than one species of sRNA exists for many amino acids. Re Inspired by the success of Edgar and his colleagues (9) in isolating a large number of conditionally expressed phage mutants using temperature as the restricting environmental parameter, we started a search 3 years ago for mutants with temperature-sensitive aminoacyl sRNA synthetases. At approximately the same time, Yanif, Jacob, and Gros (42) began similar searches, and other laboratories were using temperature-conditional mutations to aid in studying other cellular processes (14, 17, 28 Methods for isolating conditional mutants. The task of finding conditionally expressed mutants in a particular enzyme may be divided into three processes. The first involves the production (usually by mutagenesis) and isolation (sometimes by penicillin selection) of mutants that grow poorly or not at all under one of the restricting conditions described above, but well under any other condition.
The second process involves the identification of the specific enzyme lesion in the mutants isolated by one of the above procedures. This process is difficult but not impossible, and much has been learned from the behavior of mutants already identified that will facilitate future identifications. In brief, conditional mutants fact that led to the first isolation of a mutant with an altered aminoacyl sRNA synthetase. A p-fluorophenylalanine-resistant mutant of E. coli was isolated by W. Fangman in our laboratory, and was discovered to have a phenylalanyl sRNA synthetase which could still competently attach phenylalanine to sRNA but which differed from the normal enzyme in having a greatly reduced ability to attach p-fluorophenylalanine to sRNA (11, 12) .
Naturally Occurring Variants A somewhat surprising finding was made in our laboratory by Lia Faiman (at that time, Lia Eidlic) during routine screening of parental and mutant strains for aminoacyl sRNA synthetase activities. The two wild strains most commonly used by us, strains KIO and KB, were found to differ over 100-fold in their glycyl sRNA synthetase activity. Additional investigation revealed that it was the strain with the low activity, KB, that was the unusual one, for several other common laboratory strains shared the high activity of strain K10 (though strain C seemed to be intermediate). Furthermore, the very low activity of strain KB can be increased by increasing the glycine concentration in the assay system. The apparent Km for glycine is about 100 times higher for the enzyme of strain KB than that of strain K10, as measured in crude extracts (5) .
Berg and Yanofsky (cited in 6) have discovered, in addition, that a survey of large numbers of laboratory strains reveals many with markedly altered glycyl sRNA synthetase activities.
Perhaps this natural genetic variation is unique to the glycine enzyme, but if not it may prove very useful in the future to examine many laboratory strains as a potential source of useful "mu- Fig. 3 depict the behavior of a normal wild strain of E. coli KB, at 30 and 40 C in a minimal and in a rich medium. These cells grow approximately twice as fast at the higher temperature. Mutant strain 1-9 was derived from strain KB by ethylmethane sulfonate mutagenesis, followed by counterselection with penicillin in rich medium at 40 C. As shown in Fig. 3 , this mutant fails to grow at 40 C in either medium, and growth ceases fairly abruptly when the temperature is suddenly raised from the permissive to the restrictive level. The abruptness suggests inactivation of some vital enzyme rather than a failure to make it at the restrictive temperature.
The growth rate of strains KB and 1-9 in minimal medium is plotted in Fig. 4 (27) . Table 2 disclosed two interesting properties of the valyl sRNA synthetase activity of 1-9. First, of the three conventional assay procedures, the attachment reaction was the most severely damaged; the other assay systems indicated that considerable activation activity was retained by the modified enzyme. Second, valyl sRNA synthetase activity could only barely be detected by the attachment assay at 30 C, even in extracts of 1-9 cells never exposed to the restrictive temperature.
The latter finding would be expected if the mutant enzyme were extremely labile in vitro. An alternative explanation would be that 1-9 lacks a competent valyl sRNA synthetase at any temperature, and that the temperature-sensitive growth pattern and the altered enzyme activity are unrelated. Clearly it was of the utmost importance to resolve this question.
Both genetic and biochemical evidence was obtained that supported the interpretation that the mutant enzyme is temperature-sensitive in vivo and simply inactive in vitro at any temperature. Table 3 summarizes the results from many bacterial mating and viral transduction experiments (4) . When K10 (ts+ val-act+ str-s) was mated to 1-9 (ts-val-act-str-r) and ts+ str-r recombinants were selected, all of them received the val-act+ character. When the generalized transducing phase Plkc was grown on KB (ts+ val-act+) and used to infect 1-9 (ts-val-act-) at low multiplicities, transductants selected for ts+ had all received val-act+. These data make it highly likely that the ts and val-act characters are the result of a single altered chromosomal gene. a The values were determined from Lineweaver-Burke plots of kinetic results obtained by the attachment assay system on 200-fold purified preparations of the enzymes. To calculate the turnover number (moles per mole of enzyme per minute at Vmax), these preparations were assumed to be pure and the value of 160,000 was used for the molecular weight of the enzyme. From Fangman, Nass, and Neidhardt (11 The former class is by now a large one, because it is relatively simple to isolate mutants of E. coli that are resistant to p-fluorophenylalanine by virtue of an altered phenylalanyl sRNA synthetase (12) . This analogue competes with phenylalanine as a substrate for the synthetase. Even though the Km for the analogue is 150 times higher than the Km for phenylalanine, the competition results in a massive substitution of the analogue for the natural amino acid in protein synthesis in vivo. This effect most likely results both from the ability of the cells to concentrate p-fluorophenylalanine and from the ability of this compound to decrease endogenous phenylalanine biosynthesis by end-product inhibition. Substitution of phenylalanine by its p-fluoro derivative results in the formation of false (enzymatically inactive) protein, and growth is severely inhibited.
Resistance can arise by several mechanisms. Some mutants overproduce phenylalanine, even in the presence of the analogue, and the natural amino acid can then easily out-compete the analogue for the synthetase site. Other mutants have a defective concentrating mechanism and do not permit entry of the analogue. A third mechanism, however, is exhibited by mutants such as PFP-10. The phenylalanyl sRNA synthetase of this cell has been damaged in such a way that it has a 6-fold increase in Km and a 25-fold decrease in Vmax for p-fluorophenylalanine. The Km for phenylalanine has also been increased, but there has been only a twofold reduction in Vmax for this substrate (Table 6) . No detectable change has occurred in either the molecular weight or the immunochemical properties of the enzyme as a result of the mutation (11) .
There have now been several different temperature-conditional mutants identified in our laboratory as having a modified phenylalanyl sRNA synthetase. They are similar in all important respects, and in some ways resemble the temperature-conditional valyl sRNA synthetase mutants. For example, extracts of mutant strain IV-4 appear devoid of phenylalanyl sRNA synthetase activity whether or not the cells have ever been exposed to the restrictive temperature (7) . Also, considerable phenylalanine activation activity (as measured in the pyrophosphate-ATP exchange assay or the hydroxamate assay) remains despite the loss of sRNA attachment activity (Table 7) . It appears, then, that the lesions in the two enzymes are similar, and that therefore the absence of attachment activity in extracts of IV-4 is simply a result of the extreme lability of the mutated phenylalanyl sRNA synthetase under in vitro conditions; the enzyme works in vivo at 30 C but not at 40 C, and fails to work at either temperature in vitro. In fact, by assaying extracts of IV-4 cells within minutes of preparing them (i.e., omitting dialysis), it is possible to demonstrate a phenylalanyl sRNA synthetase activity that is rapidly decaying (Bock and Neidhardt, unpublished observations). Genetic evidence supports the conclusion that the temperature-sensitive growth pattern of IV-4 cells is caused by the altered synthetase. When IV-4 cells are infected at low multiplicities with phage Plkc previously grown on normal cells, all transductants selected for ability to grow at 40 C yield extracts with normal wild-type phenylalanyl sRNA synthetase activity. Furthermore, if the transducing phage are grown on PFP-10 (the mutant with the reduced ability to activate p-fluorophenylalanine), most of the temperature-resistant transductants exhibit a PFP-10-like enzyme activity (unpublished observations).
It has therefore been quite surprising for us to find that, when IV-4 cells are shifted from 30 to 40 C and protein synthesis is inhibited, the intracellular level of phenylalanyl sRNA charging does not decrease (Bock and Neidhardt, unpublished observations). Starvation of a phenylalanine auxotroph causes the usual decrease in phenylalanyl sRNA level in the cell, but at 40 C strain IV-4 behaves as if its lesion in protein synthesis were after rather than before the step of phenylalanyl sRNA formation (Table 8) .
We can suggest two possible explanations for this paradox. First, E. coli may possess a minor species of phenylalanine-specific sRNA that is not detected in the usual periodate oxidation assay for charged sRNA. The damaged IV-4 enzyme at 40 C in situ may then be unable to charge this hypothetical sRNA species, but still able to charge, at a very slow rate, the major species. Protein synthesis would halt upon exhaustion of the minor species, permitting accumulation of the acylated form of the major species.
A second explanation is that at 40 C in vivo the damaged enzyme charges the sRNA satisfactorily but fails to release the phenylalanyl sRNA complex for participation in protein synthesis on the polysomes. In either case, one would have to assume that the enzyme undergoes a further transition in vitro, destroying its ability to charge any sRNA. At the moment, there is insufficient information to rule out either of these suggestions. Table 9 lists the mutants with modified synthetases that are known at present, and Fig. 5 shows the current status of their mapping.
PHYSIOLOGICAL RESPONSES OF MUTANTS WITH
MODIFIED SYNTHETASES The existence of mutants for 6 of the 20 aminoacyl sRNA synthetases has made it possible to examine whether these enzymes are involved in regulatory phenomena, and, incidentally, to confirm the indispensable role they play in protein synthesis.
Regulation ofRNA Synthesis
The temperature-conditional synthetase mutants for valine (7, 41) , alanine (41) , and phenylalanine (Faiman, B6ck, and Neidhardt, unpublished observations) all show the same behavior when placed at their restrictive temperature: the accumulation of RNA ceases as abruptly as, or more abruptly than, the synthesis of protein. The response of the valine mutant, 1-9, is shown in Fig. 6 . This result indicates that the amino acid-mediated regulation of RNA accumulation operates not with the free amino acid but with some derivative of it that can be . 6 . Effect of a temperature shift on macromolecule synthesis in wild (KB) and mutant (1-9) strains of Escherichia coli. At the time indicated by the arrow, cultures of KB and I-9 growing in glucose-tryptone rich medium were shifted from 30 to 37 C. Samples were removed at intervals to determine the amount of DNA, RNA, and protein per milliliter in each culture by methods described elsewhere (7) . All values are normalized to the value at the time of the shift, and are plotted as a logarithmic function of time. From Neidhardt and Faiman (unpublished observations).
made only with a competent aminoacyl sRNA synthetase. It suggests, but does not rigorously prove, that aminoacyl sRNA itself is the important factor in this control device. The same conclusion can be drawn from the fact that p-fluorophenylalanine will permit RNA accumulation in a phenylalanine auxotroph with a normal phenylalanyl sRNA synthetase but fails to do so in the mutant that cannot activate this analogue (13) .
The dependence of RNA accumulation on aminoacyl sRNA synthetase activity holds true for cells with normal amino acid control (stringent), but not for cells lacking this control (relaxed). If the temperature-sensitive valyl or phenylalanyl enzymes are placed in cells with relaxed amino acid control, then an overproduction of RNA occurs at the restrictive temperature (4, 7) . This behavior is illustrated in Table 10 , which shows the response of a stringent strain (1-9) and a relaxed strain (Re24) which possess the same temperature-sensitive valyl sRNA synthetase. In the relaxed as well as the stringent cell, the level of acylated sRNA,5i falls markedly at 40 C, indicating that no other enzyme has assumed valyl sRNA synthetase function at 40 C in the relaxed cell. In the case of the temperature-sensitive phenylalanyl enzyme, as we have noted in a previous section, all of the detectable sRNAphe is acylated at the restrictive temperature whether the cell is relaxed or stringent.
These results prove that in a stringent cell both b Radioactive uracil was added at zero-time to cultures in minimal medium containing 50 jAg of uracil per ml. The data are expressed as millimicromoles of uracil incorporated by a 2-ml sample at an optical density of 1.0.
-These cultures had been pregrown in minimal medium containing uracil-2-CI4. The data are normalized to the values at zero-time.
the amino acids and their synthetases must be present for RNA to accumulate. This requirement may be explained in any of several ways. First, it has been suggested that uncharged sRNA may inhibit RNA polymerization (18, 37, 38) . In this case, the amino acid and the synthetase would both be required to neutralize the inhibitor. This possibility is made unlikely by the fact that the stringent phenylalanyl sRNA synthetase mutant ceases RNA accumulation at 40 C despite the absence of any detectable uncharged sRNAphe (though one might still postulate an undetectable sRNAphe species). Also, there is no difference between the RNA polymerases of stringent and relaxed cells, yet RNA accumulation proceeds in the latter despite the presence of unacylated sRNA. Morris and De Moss (23) and Ezekiel (10) have also described situations in which RNA regulation appears uncorrelated with the amount of uncharged sRNA.
If concomitant synthesis of a special protein is required for RNA accumulation, then the necessary participation of the aminoacyl sRNA synthetases would be obvious. This possibility, which appears so easy to test, has really not yet been eliminated. The critical experiment is to see whether RNA accumulation can occur in the total absence of protein synthesis. This situation has been approximated (e.g., with high concentrations of chloramphenicol), but it is of course difficult to establish that no protein molecules are being made under a given condition.
The recent discovery that polysomes disaggregate upon amino acid starvation (24, 30) has led to the suggestion that polysome integrity is required for RNA accumulation. This view has the advantage that it places importance on the availability of charged sRNA [and perhaps other components of protein synthesis such as guanosine triphosphate (GTP)] rather than the absolute amount of uncharged sRNA in the cell. It is supported by the findings that polysomes remain intact during amino acid starvation of relaxed cells (24, 30) , and that high concentrations of chloramphenicol induce polysome reaggregation in amino acid-starved cells (40) . It has been suggested that polysome integrity is necessary either to bind an inhibitor of RNA synthesis (24) (19) .
Repression ofBiosynthetic Enzymes
Repression of the enzymes of the valine-isoleucine pathway requires the simultaneous presence of all four of the products derived from this pathway: valine, isoleucine, leucine, and pantothenate (Fig. 7) . A limitation of any one of the products derepresses both threonine deaminase (enzyme 1) which is involved only in isoleucine synthesis, and the four enzymes which participate in valine and isoleucine synthesis (enzymes 2, 3, 4, and 5). Reaction 9 is catalyzed by relatively nonspecific transaminases. The three specific enzymes leading from a-keto-isovalerate to leucine (enzymes 6, 7, and 8) are repressed by leucine alone. sults are obtained in either minimal or in amino acid-supplemented media, and enzyme 1 shows a similar response (8) . These results, confirmed in Paris (41), indicate that valine can participate in multivalent repression only when it can be acted upon by a competent valyl sRNA synthetase. The considerable ability of I-9's valyl sRNA synthetase to catalyze valyl adenylate formation in vitro suggests that the rate-limiting process at high temperature is the sRNA attachment function of the synthetase. Therefore, the possibility that the valyl-enzyme complex, or valyl adenylate-enzyme complex, acts as a repressor is not very likely.
Rather, it would seem that to act as a corepressor valine must be attached by means of the synthetase to one or more of its cognate sRNA species, or to some still unknown apo-repressor.
Evidence is equally strong that histidyl sRNA synthetase is required to convert histidine into a repressing derivative. The Salmonella mutants were isolated as regulatory mutants. The E. coli mutant, his-C, was isolated as a histidine bradytroph, but it appears to share many of the properties of the Salmonella hisS mutants. The histidyl sRNA synthetase of his-C has an elevated Km for histidine, and whenever it is placed in a medium in which its growth is subnormal (as a result of restricted histidine activation) it is derepressed for the histidine biosynthetic enzymes (25) .
One feature of enzyme repression in synthetase mutants deserves special noting. Yanif and Gros (41) have observed that derepression of threonine deaminase (enzyme 1, Fig. 7) can be observed at temperatures slightly below that at which growth becomes detectably retarded. Some of the S. typhimurium mutants with a modified histidyl sRNA synthetase can be repressed by the addition of histidine to the minimal medium even though their growth rate is not stimulated (33) . The E. coli histidyl sRNA synthetase mutant is almost maximally derepressed when growing in rich medium containing histidine, even though its growth rate is 80% of normal (25) . Yanif and Gros (41) have pointed out that their results are consistent with the earlier chemostat studies by Gorini (15) PHAGE-INDUCED MODIFICATION OF VALYL sRNA SYNTHETASE ACTIVITY During an investigation of whether bacterial viruses utilize the translating machinery of their host cell to make protein, Mr. Earhart discovered that phage T4 infection of strain 1-9 confers upon these cells the ability to charge sRNAval and to synthesize protein at 40 C. This phenotypic conversion is correlated with the appearance of a relatively temperature-resistant valyl sRNA synthetase activity demonstrable in cell-free extracts. The new activity requires protein synthesis to develop, and appears on a schedule similar to that of phage-induced "early enzyme" synthesis. Nevertheless, there is some indication that the new activity is the result not of a totally new enzyme made de novo after phage infection, but rather the result of a modification, perhaps by subunit addition, of the pre-existing enzyme (27 biosynthesis of the amino acid from a precursor catabolite; aa-x, the co-repressor of the enzymes in the biosynthetic pathway; aa-y, the "inducer" of RNA accumulation; cat-z, the effector that functions in catabolite repression; the ellipse at the center of the figure, the aminoacyl sRNA synthetase specific for this amino acid; -aa-aa-aa-, a polypeptide chain. For further explanation see the text. 
SUMMARY AND FuTuRE GoALs
Of the six processes of bacterial cells that are linked to amino acids, four of them, protein synthesis, DNA synthesis, RNA synthesis, and biosynthetic enzyme repression, require the interaction of the amino acid with the same specific aminoacyl sRNA synthetase. The other two processes, pathway regulation and catabolite repression, are mediated by the amino acid itself acting as an inhibitor of an early enzyme in its biosynthetic pathway. Figure 10 summarizes our current knowledge of the network of regulatory devices linking each amino acid to a host of cellular processes. A precursor catabolite is shown being converted through three intermediates, a, b, and c, into an amino acid. The amino acid is acted upon by its specific aminoacyl sRNA synthetase and attached to one or more cognate sRNA species preparatory to being incorporated into a growing polypeptide chain. In addition, the synthetase is, at least for valine and histidine, responsible for making two derivatives of the amino acid: aa-x, the corepressor of the enzymes in the biosynthetic pathway; and aa-y, the "inducer" of RNA accumulation. It is possible that aa-x or aa-y, or both, are identical to one of the aa-sRNA species.
Much of the information we have about the in vivo role of aminoacyl sRNA synthetases has been obtained very recently by the use of defective mutants, many of them of the conditional type. To date, useful mutants have been obtained for 6 of the 20 synthetases, and there seems to be no reason why more cannot be obtained. Continued analysis of the mutants already at hand, and isolation of new ones, should help resolve many important questions about aminoacyl sRNA synthetases. Future goals should include the following: (i) discovery of the nature of aa-x and aa-y, the effectors in enzyme repression and RNA control, respectively, and clarification of the role of synthetases in repression by tyrosine and phenylalanine; (ii) elucidation of the fine structure of aminoacyl sRNA synthetases, including their subunit composition and the location of the amino acid and the sRNA recognition sites; (iii) resolution of the question of single versus multiple forms of synthetases for each amino acid; (iv) definition of the number of cistrons coding for each synthetase, their map location, and the nature of their products; (v) discovery of whether modified synthetases can suppress missense and nonsense mutations; (vi) description of the molecular details of synthetase function, particularly the nature and extent of its association in the cell with sRNA; (vii) discovery of how the formation of aminoacyl sRNA synthetases is regulated; and (viii) elucidation of the nature and physiological significance of phageinduced modification of synthetases.
